Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Triage of patients with moderate to severe heart failure: who should be referred to a heart failure center?

Thorvaldsen T, Benson L, Ståhlberg M, Dahlström U, Edner M, Lund LH.

J Am Coll Cardiol. 2014 Feb 25;63(7):661-71. doi: 10.1016/j.jacc.2013.10.017. Epub 2013 Oct 30.

2.

Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).

Eschalier R, McMurray JJ, Swedberg K, van Veldhuisen DJ, Krum H, Pocock SJ, Shi H, Vincent J, Rossignol P, Zannad F, Pitt B; EMPHASIS-HF Investigators.

J Am Coll Cardiol. 2013 Oct 22;62(17):1585-93. doi: 10.1016/j.jacc.2013.04.086. Epub 2013 Jun 27.

3.

Association of spironolactone use with all-cause mortality in heart failure: a propensity scored cohort study.

Lund LH, Svennblad B, Melhus H, Hallberg P, Dahlström U, Edner M.

Circ Heart Fail. 2013 Mar;6(2):174-83. doi: 10.1161/CIRCHEARTFAILURE.112.000115. Epub 2013 Feb 5.

4.

Prognosis in patients with severe heart failure referred for heart transplantation--POLKARD-HF 2003-2007.

Zieliński T, Kurjata P, Korewicki J; POLKARD-HF.

Int J Cardiol. 2010 Nov 19;145(2):242-4. doi: 10.1016/j.ijcard.2009.08.026. Epub 2009 Sep 15.

PMID:
19755203
5.

Increased comorbidities in heart failure patients ≥ 85 years but declined from >90 years: data from the Swedish Heart Failure Registry.

Holmström A, Sigurjonsdottir R, Edner M, Jonsson A, Dahlström U, Fu ML.

Int J Cardiol. 2013 Sep 10;167(6):2747-52. doi: 10.1016/j.ijcard.2012.06.095. Epub 2012 Jul 16.

PMID:
22805544
6.

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group.

J Am Coll Cardiol. 2008 Dec 2;52(23):1834-43. doi: 10.1016/j.jacc.2008.08.027. Epub 2008 Nov 7.

7.

Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity).

Wong CM, Hawkins NM, Jhund PS, MacDonald MR, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Petrie MC, McMurray JJ.

J Am Coll Cardiol. 2013 Nov 12;62(20):1845-54. doi: 10.1016/j.jacc.2013.05.072. Epub 2013 Jul 10.

8.

Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.

Gavazzi A, Berzuini C, Campana C, Inserra C, Ponzetta M, Sebastiani R, Ghio S, Recusani F.

J Heart Lung Transplant. 1997 Jul;16(7):774-85.

PMID:
9257260
9.

COPD predicts mortality in HF: the Norwegian Heart Failure Registry.

De Blois J, Simard S, Atar D, Agewall S; Norwegian Heart Failure Registry.

J Card Fail. 2010 Mar;16(3):225-9. doi: 10.1016/j.cardfail.2009.12.002. Epub 2010 Jan 6.

PMID:
20206897
10.

Impact of a specialized outpatient heart failure follow-up program on hospitalization frequency and functional status of patients with advanced heart failure.

Correia J, Silva FF, Roque C, Vieira H, Providéncia LA.

Rev Port Cardiol. 2007 Apr;26(4):335-43. English, Portuguese.

11.

Temporal trends in survival and hospitalizations in outpatients with chronic systolic heart failure in 1995 and 1999.

Senni M, De Maria R, Gregori D, Gonzini L, Gorini M, Cacciatore G, Gavazzi A, Pulignano G, Porcu M, Maggioni AP.

J Card Fail. 2005 May;11(4):270-8.

PMID:
15880335
12.

Lymphocytopenia is associated with poor NYHA functional class in chronic heart failure patients with reduced ejection fraction.

Yücel H, Refiker Ege M, Zorlu A, Kaya H, Beton O, Güngör H, Acar G, Temizhan A, Çavuşoğlu Y, Zoghi M, Eren M, Ural D, Yılmaz MB.

Turk Kardiyol Dern Ars. 2015 Jul;43(5):427-33. doi: 10.5543/tkda.2015.89439.

14.

Resource utilization and cost of heart failure associated with reduced ejection fraction in Swedish patients.

Stålhammar J, Stern L, Linder R, Sherman S, Parikh R, Ariely R, Wikström G.

J Med Econ. 2012;15(5):938-46. doi: 10.3111/13696998.2012.686464. Epub 2012 May 17.

PMID:
22510016
15.

Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.

Badano LP, Albanese MC, De Biaggio P, Rozbowsky P, Miani D, Fresco C, Fioretti PM.

J Am Soc Echocardiogr. 2004 Mar;17(3):253-61.

PMID:
14981424
16.

The burden of preserved ejection fraction heart failure in a real-world Swedish patient population.

Stålhammar J, Stern L, Linder R, Sherman S, Parikh R, Ariely R, Deschaseaux C, Wikström G.

J Med Econ. 2014 Jan;17(1):43-51. doi: 10.3111/13696998.2013.848808. Epub 2013 Oct 25.

PMID:
24066839
17.

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.

Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB; OPTIMIZE-HF Investigators and Hospitals.

J Am Coll Cardiol. 2007 Aug 21;50(8):768-77. Epub 2007 Aug 6.

18.

Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis.

Adabag S, Roukoz H, Anand IS, Moss AJ.

J Am Coll Cardiol. 2011 Aug 23;58(9):935-41. doi: 10.1016/j.jacc.2011.05.022. Review.

19.

Failure of benefit and early hazard of bucindolol for Class IV heart failure.

Anderson JL, Krause-Steinrauf H, Goldman S, Clemson BS, Domanski MJ, Hager WD, Murray DR, Mann DL, Massie BM, McNamara DM, Oren R, Rogers WJ; Beta-Blocker Evaluation of Survival Trial (BEST) Investigators.

J Card Fail. 2003 Aug;9(4):266-77.

PMID:
13680547
20.

Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.

Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, Hernandez AF, Fonarow GC; Get With the Guidelines Scientific Advisory Committee and Investigators.

Circulation. 2012 Jul 3;126(1):65-75. doi: 10.1161/CIRCULATIONAHA.111.080770. Epub 2012 May 21.

Supplemental Content

Support Center